Thank you for being a valued part of the CNET community. As of December 1, 2020, the forums are in read-only format. In early 2021, CNET Forums will no longer be available. We are grateful for the participation and advice you have provided to one another over the years.

Thanks,

CNET Support

Praise

Great news!

May 1, 2018 1:15PM PDT
http://www.philly.com/philly/business/spark-therapeutics-jackpot-jazz-pharmaceuticals-fda-luxturna-prv-20180430.html?mobi=true
2nd time in history. John 9:32. And, gene therapy is a solution for "Adamitis". Gen 3.
Now, work on price, availability, full limb transplants ditto [Mt 12:13], terminal illnesses ditto [Lu 17:14,15; 8:55] and we'll be in good shape.
Those outside the treatment parameters can wait a while, if these are historical. Gen 1:28. If not, well, $850 grand is better than no sight at all.

Discussion is locked